Endometrial carcinoma

Current Treatment Options in Oncology

Volumn 2, Issue 2, 2001, Pages 129-135

  Huh, Warner K ^a   Straughn, J Michael ^a   Kelly, F Joseph ^a   Kilgore, Larry C ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Endometrial Cancer; Endometrial Carcinoma; Myometrial Invasion; Obstet Gynecol; Oncol

Indexed keywords

ENDOMETRIUM TUMOR; FEMALE; HUMAN; HYSTERECTOMY; LYMPHADENECTOMY; PATHOLOGY; PRACTICE GUIDELINE; REVIEW; THORACIC AORTA;

AORTA, THORACIC; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; PRACTICE GUIDELINES;

EID: 0035323028     PISSN: 15272729     EISSN: 15346277     Source Type: Journal    
DOI: 10.1007/s11864-001-0055-z     Document Type: Article

References (42)

1. Greenlee RT, Murray T, Bolden S, et al.: Cancer statistics, 2000. CA Cancer J Clin 2000, 50:7–33. DOI: 10.3322/canjclin.50.1.7
2. Corn BW: Intermediate-risk endometrial cancer. A management approach. Am J Clin Oncol 1996, 19:631–635. DOI: 10.1097/00000421-199612000-00021
3. Weiss MF, Connell PP, Waggoner S, et al.: External pelvic radiation therapy in stage IC endometrial carcinoma. Obstet Gynecol 1999, 93:599–602. DOI: 10.1016/S0029-7844(98)00479-7
4. Aalders J, Abeler V, Kolstad P, et al.: Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 1980, 56:419–427.
5. Creutzberg CL, van Putten WL, Koper PC, et al.: Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma. Lancet 2000, 355:1404–1411. A large prospective trial showing no survival benefit from postoperative radiation therapy in endometrial cancer patients. DOI: 10.1016/S0140-6736(00)02139-5
6. Boronow RC: Surgical staging of endometrial cancer: evolution, evaluation, and responsible challenge—a personal perspective. Gynecol Oncol 1997, 66:179–189. DOI: 10.1006/gyno.1997.4732
7. Creasman WT, Morrow CP, Bundy BN, et al.: Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 1987, 60:2035–2041. DOI: 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8
8. Orr Jr JW, Orr PF, Taylor PT: Surgical staging endometrial cancer. Clin Obstet Gynecol 1996, 39:656–668. DOI: 10.1097/00003081-199609000-00014
9. Cowles TA, Magrina JF, Masterson BJ, et al.: Comparison of clinical and surgical-staging in patients with endometrial carcinoma. Obstet Gynecol 1985, 66:413–416.
10. Creasman WT, DeGeest K, DiSaia PJ, et al.: Significance of true surgical pathologic staging: a Gynecologic Oncology Group Study. Am J Obstet Gynecol 1999, 181:31–34. DOI: 10.1016/S0002-9378(99)70431-X
11. Wolfson AH, Sightler SE, Markoe AM, et al.: The prognostic significance of surgical staging for carcinoma of the endometrium. Gynecol Oncol 1992, 45:142–146. DOI: 10.1016/0090-8258(92)90276-O
12. Belinson JL, Lee KR, Badger GJ, et al.: Clinical stage I adenocarcinoma of the endometrium—analysis of recurrences and the potential benefit of staging lymphadenectomy. Gynecol Oncol 1992, 44:17–23. DOI: 10.1016/0090-8258(92)90005-4
13. Petereit DG: Complete surgical staging in endometrial cancer provides prognostic information only. Semin Radiat Oncol 2000, 10:8–14. DOI: 10.1016/S1053-4296(00)80015-6
14. Barnes MN, Kilgore LC: Complete surgical staging of early endometrial adenocarcinoma: optimizing patient outcomes. Semin Radiat Oncol 2000, 10:3–7. DOI: 10.1016/S1053-4296(00)80014-4
15. Fanning J, Nanavati PJ, Hilgers RD: Surgical staging and high dose rate brachytherapy for endometrial cancer: limiting external radiotherapy to nodepositive tumors. Obstet Gynecol 1996, 87:1041–1044. DOI: 10.1016/0029-7844(96)00055-5
16. Chen SS: Operative treatment in stage I endometrial carcinoma with deep myometrial invasion and/or grade 3 tumor surgically limited to the corpus uteri. No recurrence with only primary surgery. Cancer 1989, 63:1843–1845. DOI: 10.1002/1097-0142(19900501)63:9<1843::AID-CNCR2820630931>3.0.CO;2-F
17. Naumann RW, Higgins RV, Hall JB: The use of adjuvant radiation therapy by members of the Society of Gynecologic Oncologists. Gynecol Oncol 1999, 75:4–9. DOI: 10.1006/gyno.1999.5548
18. Gretz HF, Economos K, Husain A, et al.: The practice of surgical staging and its impact on adjuvant treatment recommendations in patients with stage I endometrial carcinoma. Gynecol Oncol 1996, 61:409–415. DOI: 10.1006/gyno.1996.0165
19. Chuang L, Burke TW, Tornos C, et al.: Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes. Gynecol Oncol 1995, 58:189–193. DOI: 10.1006/gyno.1995.1208
20. Arango HA, Hoffman MS, Roberts WS, et al.: Accuracy of lymph node palpation to determine need for lymphadenectomy in gynecologic malignancies. Gynecol Oncol 2000, 95:553–556.
21. Girardi F, Petru E, Heydarfadai M, et al.: Pelvic lymphadenectomy in the surgical treatment of endometrial cancer. Gynecol Oncol 1993, 49:177–180. DOI: 10.1006/gyno.1993.1103
22. Daniel AG, Peters WA: Accuracy of office and operating room curettage in the grading of endometrial carcinoma. Obstet Gynecol 1988, 71:612–614.
23. Larson DM, Johnson KK, Broste SK, et al.: Comparison of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer. Obstet Gynecol 1995, 86:38–42. DOI: 10.1016/0029-7844(95)00105-Z
24. Kim YB, Niloff JM: Endometrial carcinoma: analysis of recurrence in patients treated with a strategy minimizing lymph node sampling and radiation therapy. Obstet Gynecol 1993, 82:175–180.
25. Goff BA, Rice LW: Assessment of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol Oncol 1990, 38:46–48. DOI: 10.1016/0090-8258(90)90009-A
26. Zorlu CG, Kuscu E, Ergun Y, et al.: Intraoperative evaluation of prognostic factors in stage I endometrial cancer by frozen section: how reliable? Acta Obstet Gynecol Scand 1993, 72:382–385.
27. Orr Jr JW, Holimon JL, Orr PF: Stage I corpus cancer: is teletherapy necessary? Am J Obstet Gynecol 1997, 176:777–788. A large study of endometrial cancer patients demonstrating low morbidity with lymphadenectomy. DOI: 10.1016/S0002-9378(97)70601-X
28. Mohan DS, Samuels MA, Selim MA, et al.: Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol 1998, 70:165–171. DOI: 10.1006/gyno.1998.5098
29. Kilgore LC, Partridge EE, Alvarez RD, et al.: Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 1995, 56:29–33. A retrospective review of endometrial cancer patients demonstrating a therapeutic benefit with lymphadenectomy. DOI: 10.1006/gyno.1995.1005
30. Mariani A, Webb MJ, Galli L, et al.: Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecol Oncol 2000, 76:348–356. DOI: 10.1006/gyno.1999.5688
31. Homesley HD, Kadar N, Barrett RJ, et al.: Selective pelvic and periaortic lymphadenectomy does not increase morbidity in surgical staging of endometrial carcinoma. Am J Obstet Gynecol 1992, 167:1225–1230.
32. Larson DM, Johnson K, Olson KA: Pelvic and paraaortic lymphadenectomy for surgical staging of endometrial cancer: morbidity and mortality. Obstet Gynecol 1992, 79:998–1001.
33. Larson DM, Johnson KK: Pelvic and para-aortic lymphadenectomy for surgical staging of high-risk endometrioid adenocarcinoma of the endometrium. Gynecol Oncol 1993, 51:345–348. DOI: 10.1006/gyno.1993.1301
34. Orr JW: Surgical staging of endometrial cancer: does the patient benefit? Gynecol Oncol 1998, 71:335–339. DOI: 10.1006/gyno.1998.5296
35. Partridge EE, Jessup JM, Donaldson ES, et al.: 1996 patient care evaluation study (PCE) of cancer of the corpus uteri, National Cancer Database (NCDB), American College of Surgery. Gynecol Oncol 1999, 72:444.
36. Corn BW, Lanciano RM, Greven KM, et al.: Impact of improved irradiation technique, age, and lymph node sampling on the severe complication rate of surgically staged endometrial cancer patients: a multivariate analysis. J Clin Oncol 1994, 12:510–515.
37. Moore DH, Fowler Jr WC, Walton LA, et al.: Morbidity of lymph node sampling in cancers of the uterine corpus and cervix. Obstet Gynecol 1989, 74:180–184.
38. Ashih H, Gustilo-Ashby T, Myers ER, et al.: Costeffectiveness of treatment of early stage endometrial cancer. Gynecol Oncol 1999, 74:208–216. DOI: 10.1006/gyno.1999.5427
39. Fanning J: Treatment for early endometrial cancer. Cost-effectiveness analysis. J Reprod Med 1999, 44:719–723.
40. Barnes MN, Roland PY, Straughn M, et al.: A comparison of treatment strategies for endometrial adenocarcinoma: analysis of financial impact. Gynecol Oncol 1999, 74:443–447. A cost analysis evaluating the cost effectiveness of surgical staging and adjuvant radiation in endometrial cancer patients. DOI: 10.1006/gyno.1999.5480
41. Konski AA, Bracy PM, Jurs SG, et al.: Cost minimization analysis of various treatment options for surgical stage I endometrial carcinoma. Int J Radiat Oncol Biol Phys 1997, 37:367–373. DOI: 10.1016/S0360-3016(96)00492-0
42. Straughn JM, Stringer J, Barnes MN, et al.: Choosing the appropriate treatment for endometrial adenocarcinoma: a cost-effectiveness analysis. Gynecol Oncol 2000, 76:251.